Tetsuo Ohashi

493 total citations
27 papers, 367 citations indexed

About

Tetsuo Ohashi is a scholar working on Surgery, Nephrology and Rheumatology. According to data from OpenAlex, Tetsuo Ohashi has authored 27 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Nephrology and 10 papers in Rheumatology. Recurrent topics in Tetsuo Ohashi's work include Gout, Hyperuricemia, Uric Acid (13 papers), Case Reports on Hematomas (12 papers) and Liver Disease and Transplantation (5 papers). Tetsuo Ohashi is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (13 papers), Case Reports on Hematomas (12 papers) and Liver Disease and Transplantation (5 papers). Tetsuo Ohashi collaborates with scholars based in Japan. Tetsuo Ohashi's co-authors include Tatsuo Hosoya, Tomomitsu Sasaki, Hiroya Hashimoto, Yoshihiro Ogawa, Yasuo Ito, Hideo Kato, Tetsuhiko Sasaki, Ken IKEUCHI, Marco Hiroshi Naka and Koji Hattori and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Pharmacology and Journal of Orthopaedic Research®.

In The Last Decade

Tetsuo Ohashi

27 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuo Ohashi Japan 13 243 152 93 64 58 27 367
Shigeyuki Miyamura Japan 9 142 0.6× 44 0.3× 11 0.1× 28 0.4× 118 2.0× 17 361
Masanori Kawachi Japan 9 81 0.3× 42 0.3× 102 1.1× 29 0.5× 136 2.3× 31 309
Dimitra Kalavrizioti Greece 11 62 0.3× 43 0.3× 15 0.2× 43 0.7× 88 1.5× 22 320
Alice Mazur United States 11 95 0.4× 40 0.3× 66 0.7× 78 1.2× 164 2.8× 13 570
Paola Rodrı́guez Spain 7 109 0.4× 12 0.1× 28 0.3× 45 0.7× 35 0.6× 15 203
Ki Hyun Park South Korea 13 24 0.1× 91 0.6× 85 0.9× 22 0.3× 102 1.8× 35 479
David E. Burgio United States 14 145 0.6× 53 0.3× 26 0.3× 48 0.8× 107 1.8× 18 576

Countries citing papers authored by Tetsuo Ohashi

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Ohashi more than expected).

Fields of papers citing papers by Tetsuo Ohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Ohashi. The network helps show where Tetsuo Ohashi may publish in the future.

Co-authorship network of co-authors of Tetsuo Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Ohashi. A scholar is included among the top collaborators of Tetsuo Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Ohashi. Tetsuo Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosoya, Tatsuo, et al.. (2020). Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study. Clinical and Experimental Nephrology. 24(S1). 62–70. 31 indexed citations
2.
Sasaki, Tomomitsu, et al.. (2020). Ideal pharmacokinetic profile of dotinurad as a selective urate reabsorption inhibitor. Drug Metabolism and Pharmacokinetics. 35(3). 313–320. 16 indexed citations
3.
Nakatani, Hiroshi, et al.. (2019). Pharmacokinetic/pharmacodynamic modeling and simulation of dotinurad, a novel uricosuric agent, in healthy volunteers. Pharmacology Research & Perspectives. 7(6). e00533–e00533. 14 indexed citations
4.
5.
6.
7.
Hosoya, Tatsuo, et al.. (2019). Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout. Clinical and Experimental Nephrology. 24(S1). 80–91. 21 indexed citations
8.
Nakatani, Hiroshi, et al.. (2019). Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects. Clinical and Experimental Nephrology. 24(S1). 8–16. 6 indexed citations
9.
Fukase, Hiroyuki, et al.. (2019). Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor. Clinical and Experimental Nephrology. 24(S1). 17–24. 6 indexed citations
10.
Hosoya, Tatsuo, et al.. (2018). Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout. Clinical Drug Investigation. 38(12). 1135–1143. 14 indexed citations
11.
Hosoya, Tatsuo, Tomomitsu Sasaki, & Tetsuo Ohashi. (2016). Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study. Clinical Rheumatology. 36(3). 649–656. 43 indexed citations
12.
Nakagawa, Yasuaki, Koji Mori, Mikihito Takenaka, et al.. (2007). Estimation of the mechanical property of meniscus using ultrasound: Examinations of native meniscus and effects of enzymatic digestion. Journal of Orthopaedic Research®. 25(7). 884–893. 11 indexed citations
13.
Naka, Marco Hiroshi, Koji Hattori, Tetsuo Ohashi, & Ken IKEUCHI. (2005). Evaluation of the effect of collagen network degradation on the frictional characteristics of articular cartilage using a simultaneous analysis of the contact condition. Clinical Biomechanics. 20(10). 1111–1118. 15 indexed citations
14.
Yamada, Takatoshi, Yoshimasa Takahashi, Masayuki Ishizaki, et al.. (2003). Effects of RS-601, a Novel Leukotriene D<sub>4</sub>/Thromboxane A<sub>2</sub> Dual Receptor Antagonist, on Asthmatic Responses in Guinea Pigs. Pharmacology. 69(1). 51–58. 8 indexed citations
15.
Oshita, Masafumi, et al.. (1998). Pharmacological characterization of HSR-609, a novel amphoteric antiallergic agent. The Japanese Journal of Pharmacology. 76. 165–165. 1 indexed citations
16.
Ohashi, Tetsuo, Shigeki Hashimoto, Kouji Morikawa, et al.. (1996). Potent inhibition of spontaneous rhythmic contraction by a novel β2-adrenoceptor agonist, HSR-81, in pregnant rat uterus. European Journal of Pharmacology. 307(3). 315–322. 8 indexed citations
17.
18.
19.
Ohashi, Tetsuo, Shigeki Hashimoto, Kouji Morikawa, et al.. (1994). Potent inhibition of spontaneous rhythmic contraction by a novel β2-adrenoceptor agonist, HSR-81, in pregnant rat uterus.. The Japanese Journal of Pharmacology. 64. 212–212. 3 indexed citations
20.
Makino, Eiichi, Nobuhiro Yagi, Tetsuo Ohashi, et al.. (1990). Studies on antiallergic agents. I. Synthesis and antiallergic activity of novel pyrazine derivatives.. Chemical and Pharmaceutical Bulletin. 38(1). 201–207. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeyuki Miyamura Breakdown of academic impact, for papers by Masanori Kawachi Breakdown of academic impact, for papers by Dimitra Kalavrizioti Breakdown of academic impact, for papers by Alice Mazur Breakdown of academic impact, for papers by Paola Rodrı́guez Breakdown of academic impact, for papers by Ki Hyun Park Breakdown of academic impact, for papers by David E. Burgio
Rankless by CCL
2026